MIT professor joins Constant Therapy’s Scientific Advisory Board

162

Constant Therapy, a developer of a cloud-based iPad solution enabling people with cognitive, language, communication and learning disorders to access science-based brain therapies, has announced that John Gabrieli, Massachusetts Institute of Technology (MIT) Brain and Cognitive Sciences professor, has joined the company’s Scientific Advisory Board.

A press release reports that Gabrieli is the director of the Athinoula A Martinos Imaging Centre at the McGovern Institute for Brain Research at MIT. He is an investigator at the Institute, with faculty appointments in the Department of Brain and Cognitive Sciences and the Institute for Medical Engineering & Science, where he has the Grover Hermann Professorship. Prior to joining MIT, he spent 14 years at Stanford University in the Department of Psychology and Neurosciences Programme. Since 1990, he has served as visiting professor, Department of Neurological Sciences, Rush-Presbyterian-St. Luke’s Hospital and Rush Medical College.

“I am excited to be a part of Constant Therapy as it is transforming the delivery of brain rehabilitation and will help brain injury survivors to recover in ways never before possible. This is important work; the analytics provided by Constant Therapy is a key enabler in understanding how the brain responds to different courses of therapy and will be invaluable in allowing us to optimise therapies unique to individual patients,” Gabrieli says.